Analyst Price Targets — VTRS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 19, 2026 9:18 am | Glen Santangelo | Barclays | $22.00 | $16.50 | TheFly | Viatris price target raised to $22 from $17 at Barclays |
| May 8, 2026 1:28 pm | — | Truist Financial | $20.00 | $16.95 | TheFly | Viatris price target raised to $20 from $18 at Truist |
| February 9, 2026 10:05 am | Ashwani Verma | UBS | $18.00 | $14.58 | TheFly | Viatris upgraded to Buy from Neutral at UBS |
| January 28, 2026 11:49 am | — | Piper Sandler | $12.00 | $13.12 | TheFly | Viatris price target raised to $12 from $9 at Piper Sandler |
| January 16, 2026 12:14 pm | — | Argus Research | $15.00 | $12.84 | TheFly | Argus upgrades Viatris to Buy on expected buybacks, debt reduction |
| January 7, 2026 12:22 pm | Les Sulewski | Truist Financial | $16.00 | $12.40 | TheFly | Viatris price target raised to $16 from $15 at Truist |
| October 15, 2025 10:07 am | — | Truist Financial | $15.00 | $9.93 | TheFly | Viatris initiated with a Buy at Truist |
| July 19, 2024 8:05 am | Glen Santangelo | Jefferies | $15.00 | $11.77 | TheFly | Viatris reinstated with a Buy at Jefferies |
| March 28, 2024 6:40 am | David Amsellem | Piper Sandler | $13.00 | $11.83 | StreetInsider | Viatris (VTRS) PT Raised to $13 at Piper Sandler on latest Idorsia deals |
| June 26, 2023 9:08 am | David Amsellem | Piper Sandler | $10.00 | $9.84 | Benzinga | Check Out 3 Health Care Stocks With Over 4% Dividend Yields From Wall Street's Most Accurate Analysts |
Latest News for VTRS
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Investors interested in Medical Services stocks are likely familiar with Viatris (VTRS) and Danaher (DHR). But which of these two companies is the best option for those looking for undervalued stocks?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Healthcare has been an unloved corner of the market in 2026, but that neglect has created a rare setup: quality names trading in single-digit and low-double-digit territory while still throwing off cash, growing earnings, and reaffirming guidance.
Growth premium vs. value recovery, one trades at 33x forward earnings while the other navigates debt reduction and biosimilar expansion.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.